Our Journey

Father and daughter release white paper lanterns into the sky

Viatris: A bold history and bright future

Imagine if we were all focused on healthcare not as it is, but as it should be – and we did everything we could to make it happen. That’s the aim of newly launched global pharmaceutical company Viatris. Formed by the combination of Mylan and Upjohn, Viatris is focused on empowering people to live healthier at every stage of life.

Viatris reaches patients in more than 165 countries and territories with more than 1,400 molecules spanning approximately 10 therapeutic areas, employs approximately 45,000 people, operates more than 50 manufacturing sites and has a 24/7 research and development platform committed to innovating around the clock to meet unmet needs. Our company’s unique Global Healthcare GatewayTM is powered by Viatris’ unmatched global infrastructure and expertise, which will offer others the ability to further empower their own assets to reach more patients worldwide by leveraging our global commercial reach, global supply chain, expansive regulatory and technical expertise and global cost efficient manufacturing platform.

165+
countries and territories
1,400+
molecules
10+
therapeutic areas
45,000+
employees worldwide
~50
manufacturing sites